Patent · US Active

Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

US8546548B2 · kind B2 · utility

12Cited by

9References

16Claims

0Family size

Assignees

Baxter International Inc. · US
Baxter Healthcare SA · CH

Inventors

Wolfgang Teschner · Wien, AT
Harald Arno Butterweck · Wien, AT
Azra Pljevljakovic · Wien, AT
Theresa Friederike Bauer · Wien, AT
Bernhard Koelbl · Achau, AT
Hans-Peter Schwarz · Wien, AT
Nebojsa Nikolic · Wien, AT
Gerhard Poelsler · Wien, AT
Johanna Kindermann · Mödling, AT

Key dates

Filing date	May 27, 2010
Grant date	Oct 1, 2013
Priority date	—
Expiry date	May 29, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/21
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a new and improved method for preparing a highly concentrated immunoglobulin composition from pooled plasma for subcutaneous injection. A composition comprising 20% or more immunoglobulin suitable for subcutaneous use is also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.